+31 412 846 000
Discovering Novel Antibody-Based Diagnostics and Therapeutics To Address Unmet Medical Needs
Antibody Diagnostics
ModiQuest founders developed the first diagnostics test for rheumatoid arthritis, marketed worldwide and included in the American College of Rheumatology (ACR) diagnostics criteria.
Read more >>Antibody Therapeutics
ModiQuest's pipeline of preclinical candidates includes monoclonal and recombinant antibody therapeutics for prevention and treatment of established rheumatoid arthritis.
Read more >>About ModiQuest
Experts in monoclonal and recombinant antibody generation for autoimmune and oncology, with high throughput hybridoma and phage display technology.
Read more >>Latest News
- Immunoprecise and Harbour Antibodies announce technology co-offering agreement for next-generation fully-human antibody discovery
- ImmunoPrecise Antibodies’ Annual Revenues Increase 106% to 5.4 Million
- ImmunoPrecise Increases Private Placement Financing to $7 Million
- IMMUNOPRECISE ANNOUNCES $2 MILLION FINANCING